Cargando…
Inhibition of Na(V)1.8 prevents atrial arrhythmogenesis in human and mice
Pharmacologic approaches for the treatment of atrial arrhythmias are limited due to side effects and low efficacy. Thus, the identification of new antiarrhythmic targets is of clinical interest. Recent genome studies suggested an involvement of SCN10A sodium channels (Na(V)1.8) in atrial electrophys...
Autores principales: | Pabel, Steffen, Ahmad, Shakil, Tirilomis, Petros, Stehle, Thea, Mustroph, Julian, Knierim, Maria, Dybkova, Nataliya, Bengel, Philipp, Holzamer, Andreas, Hilker, Michael, Streckfuss-Bömeke, Katrin, Hasenfuss, Gerd, Maier, Lars S., Sossalla, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033079/ https://www.ncbi.nlm.nih.gov/pubmed/32078054 http://dx.doi.org/10.1007/s00395-020-0780-8 |
Ejemplares similares
-
The functional consequences of sodium channel Na(V)1.8 in human left ventricular hypertrophy
por: Ahmad, Shakil, et al.
Publicado: (2018) -
Molecular and Functional Relevance of Na(V)1.8-Induced Atrial Arrhythmogenic Triggers in a Human SCN10A Knock-Out Stem Cell Model
por: Hartmann, Nico, et al.
Publicado: (2023) -
Detrimental proarrhythmogenic interaction of Ca(2+)/calmodulin-dependent protein kinase II and Na(V)1.8 in heart failure
por: Bengel, Philipp, et al.
Publicado: (2021) -
Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes
por: Pabel, Steffen, et al.
Publicado: (2020) -
Effects of Atrial Fibrillation on the Human Ventricle
por: Pabel, Steffen, et al.
Publicado: (2022)